Navigation Links
International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
Date:8/22/2007

Agreement could potentially double annual sales

IDAHO FALLS, Idaho, Aug. 22 /PRNewswire-FirstCall/ -- International Isotopes Inc. (OTC Bulletin Board: INIS), announces it has entered into an agreement with Alpha Omega Services (AOS), of Bellflower California, to be their exclusive worldwide distributor for a new family of Type B(U) radioactive material transportation containers.

AOS has been working on the development and licensing of these containers, as well as working with INIS on the distributor agreement, for about two years. These AOS containers will be the newest Type B(U) package designed in the United States and will meet all of the most current International Atomic Energy Agency regulations for the safe transport of radioactive material. The AOS containers are intended to replace dozens of models of radioactive material containers currently used by U.S. government and commercial interests that will no longer be approved for use in the U.S. after October 1, 2008. Those containers include the entire inventory of Department of Transportation 20 WC series Specification Packages as well as many of the packages previously approved by the NRC that were designed and tested against the 1967, 1973, and 1973A Editions of TS-R-1 regulations.

Steve T. Laflin, President and CEO, said, "The change in Type B container regulations has created a significant opportunity for the Company. We expect revenue realized through this distributor agreement could potentially double our annual sales. The AOS containers will be offered in a range of sizes and capacities that will permit them to meet a wide range of applications including transportation of radioisotopes, activated materials, and even irradiated fuel. The versatility of these containers, and the elegance of their design, is expected to make them attractive to customers looking for alternatives to containers that will lose their approval status in the coming year. INIS and AOS will be pr
'/>"/>

SOURCE International Isotopes Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Olympics of biotechnology has international flavor
2. Traffic data firm navigates international business
3. Catalyst International profit exceeds expectations
4. Lack of broadband hamstrings international videoconferencing
5. 30 days to success: Three simple steps to create your own international startup
6. TEKLYNX International announces new RFID software
7. Ruling enforces international trademark electronic filing requirements
8. Eleftheriou to lead Catalyst International
9. Internet trademark war goes international
10. International eyes drawn to Madisons games research
11. Plexus and SRI International team up to offer medical product development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...3/PRNewswire-FirstCall/-YMBioSciencesInc.(NYSEAmex...anythatidentifiesandadvancesadiverseportfolioofpro...opment,todayreportedthatCytopia(ASX:CYT)hascommenc...ent,orally-administeredJAK1/JAK2inhibitor.Thetrial...AproposaltomergeCytopiaintoYMhasbeenpreviouslyanno...
(Date:11/23/2009)...Newswire/-InimexPharmaceuticals,Inc.announcedtoday...ntandCEO. ,, Abramsbringsmorethan25yearsofdrugd...nventorofthenuclearmedicineimagingagent,Cardiolite...ewasManager,BiomedicalResearchWorldwide.In1996,Abr...residentandCEOfrom1996to2006.AnorMEDdiscoveredandd...
(Date:11/20/2009)... , , , , , , , ... , A team of scientists from Washington Univers...Spring Harbor Laboratory and Iowa State University..., , Click here for more informatio... , , , , , , , ...
(Date:11/20/2009)... Nov. 20 Novavax, Inc. (... an underwritten public offering of 6,800,000 shar... $3.30 per share. The approximately $21 million o...iscounts and commissions, will be used for preclin...vaccines, internal research and development progra...
Breaking Biology Technology:YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Inimex Announces Appointment of New CEO 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Novavax Prices Public Offering of Common Stock 2
...o ensure the effectiveness of your companys next w...(quite literally) through the process of paper pro... method of testing web site designs. It involves c...viting some of your users to take the design for a...o complete important tasks. , ,As users explore t...
...: The Wisconsin Technology Council has published ...nces industry. The 24-page publication highlights ...ess, company creation, quality of life, key contac...sin and Minneapolis-St. Paul. , ,The Wisconsin Te...m Life Sciences: Wisconsin The Smart Choice , ov...
...consins inner-city and minority entrepreneurs face...as well as the resources designed to overcome them...Entrepreneurs Conference in Milwaukee. A panel con...es , Art Smith, chief executive officer of the Ini...l, executive director of Green Bay-based Urban Hop...
Other Biology Technology:How Good Does Your Web Site Look on Paper? 2Life Science: From company creation to growth: Doing business in Wisconsin 2Life Science: From company creation to growth: Doing business in Wisconsin 3Life Science: From company creation to growth: Doing business in Wisconsin 4Life Science: From company creation to growth: Doing business in Wisconsin 5Minority and inner-city entrepreneurs face challenges 2Minority and inner-city entrepreneurs face challenges 3
(Date:11/23/2009)...erman . , Of all global carbon dioxide emiss...where it contributes to global warming. The remain...stems such as forests, grasslands and peat-lands. ...restrial ecosystems is considered one of the main,...ange. However, new greenhouse gas bookkeeping has ...
(Date:11/22/2009)...on can increase the likelihood of immune complicat...ernational team of researchers reports in the Nove... When the gene, called UGT2B17, is missing from th...ransplants have a significantly greater risk of a ...ease, in which immune cells from the donor attack ...
(Date:11/21/2009)...2009 / b3c newswire / - KINAXO Biotechnologies G..., gaining two new investors in the company, Leifin...ts that Jrgen Schumacher has been elected as a new... shareholders Axel Ullrich, Hellmut Kirchner, Manf...nvestors Mountain Partners, BioM, High-Tech Grnder...
Breaking Biology News(10 mins):Intensive land management leaves Europe without carbon sinks 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3Solta Medical Inc Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank 50819 1Solta Medical Inc Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank 50819 2Solta Medical Inc Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank 50819 3Ancient fossils shed light on anatomical changes accompanying evolution of first land vertebrates 50817 1Ancient fossils shed light on anatomical changes accompanying evolution of first land vertebrates 50817 2Chance to Protect Babies from Toxic Chemicals Faced by CA State Assembly 50815 1Chance to Protect Babies from Toxic Chemicals Faced by CA State Assembly 50815 2
...Two international teams of researchers have made s...s of psoriasis, a chronic skin condition that can ...involving thousands of patients, is reported in tw...e Nature Genetics . , "Taken together, the stud... personalized medicine," says a senior author of b...
...The National Institutes of Health (NIH) has awarde...formatics support for researchers conducting small...o-year contracts, which will total up to an estima...ndividuals at three or more institutions that rece...(CTSA). Administered by the National Center for Re...
...Today, BioMed Central,s premier open access medica...d with the publication of its January 2009 issue. ...cal advances and is one of fastest growing areas o...f the human genome and proteome is making it possi...human disease, and to offer a new set of tools for...
Other Biology News:Scientists uncover new genetic variations linked to psoriasis 2Scientists uncover new genetic variations linked to psoriasis 33 new informatics pilot projects to aid clinical and translational scientists nationwide 2Genome Medicine: Bridging the gap between research and clinical practice 2
...OVOstar is an exciting product for cell-based kine...ell-based assays required the use of expensive HTS...r scientists in the assay development stage. The N...ell-based assays as well as any other assay suitab...
...igital Clamp One can operate as a Voltage Clamp, a...amp in electrophysiology research applications. Pe...al analog equipment. • This amazing instr...the capabilities of Digital Signal Processing (DSP...
Dispensing Bins from Terra Universal, Inc.
Agilent MSD Security ChemStation for GC and GC/MS from Agilent Technologies
Biology Products: